Literature DB >> 7009136

Adverse effects of antiarrhythmic drugs.

J B Schwartz, D Keefe, D C Harrison.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7009136     DOI: 10.2165/00003495-198121010-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  136 in total

1.  THE SYMPATHOMIMETIC ACTION OF BRETYLIUM OF ISOLATED ATRIA AND AORTIC SMOOTH MUSCLE.

Authors:  S M KIRPEKAR; R F FURCHGOTT
Journal:  J Pharmacol Exp Ther       Date:  1964-01       Impact factor: 4.030

Review 2.  Digitalis. I.

Authors:  T W Smith; E Haber
Journal:  N Engl J Med       Date:  1973-11-01       Impact factor: 91.245

3.  A peculiar cutaneous pigmentation from cordarone.

Authors:  A K Vos; A G van Ramshorst; J C Grosfeld; J P Goossens
Journal:  Dermatologica       Date:  1972

4.  Asystole after verapamil.

Authors:  M E Benaim
Journal:  Br Med J       Date:  1972-04-15

5.  Procainamide induction of a systemic lupus erythematosus-like syndrome. Presentation of six cases, review of the literature, and analysis and followup of reported cases.

Authors:  E L Dubois
Journal:  Medicine (Baltimore)       Date:  1969-05       Impact factor: 1.889

6.  Immune hemolytic anemia and thrombocytopenia secondary to quinidine: in vitro studies of the quinidine-dependent red cell and platelet antibodies.

Authors:  Z Zeigler; R K Shadduck; A Winkelstein; T K Stroupe
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

7.  Hépatotoxicity due to n-propyl ajmaline bitartrate. Report of a case.

Authors:  M Weiss; E Theodor; H Bank
Journal:  Med Chir Dig       Date:  1978

8.  Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.

Authors:  P J Podrid; A Lyakishev; B Lown; N Mazur
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

9.  Open clinical studies at a referral center: chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agents.

Authors:  J D Maloney; R G Nissen; J M McColgan
Journal:  Am Heart J       Date:  1980-12       Impact factor: 4.749

10.  Transient cholestasis during treatment with ajmaline, and chronic xanthomatous cholestasis after administration of ajmaline, methyltestosterone and ethinylestradiol. Two case reports.

Authors:  B Beermann; J L Ericsson; K Hellström; B Wengle; B Werner
Journal:  Acta Med Scand       Date:  1971-10
View more
  13 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

Review 2.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 3.  Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Authors:  K A Muhiddin; P Turner
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

Review 4.  Clinical pharmacokinetics in heart failure. An updated review.

Authors:  F V Shammas; K Dickstein
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

Review 5.  Recent advances in cardiology.

Authors:  E A Rodrigues; D J Coltart
Journal:  Postgrad Med J       Date:  1982-08       Impact factor: 2.401

Review 6.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

7.  Tricyclic antidepressant poisoning. Management of arrhythmias.

Authors:  P R Pentel; N L Benowitz
Journal:  Med Toxicol       Date:  1986 Mar-Apr

8.  Amiodarone and pulmonary fibrosis.

Authors:  J Morera; R Vidal; F Morell; J Ruiz; L Bernadó; J R Laporte
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Ajmaline test in a patient with chronic renal failure. A pharmacokinetic and pharmacodynamic study.

Authors:  R Padrini; L Compostella; D Piovan; A Javarnaro; F Cucchini; M Ferrari
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

10.  Antiarrhythmic drugs and polyneuropathy. The Collaborative Group for the Study of Polyneuropathy.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.